Sage Therapeutics (SAGE)
(Real Time Quote from BATS)
$7.45 USD
+0.14 (1.92%)
Updated Sep 25, 2024 10:50 AM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -1.54 |
EPS Last Quarter | -1.70 |
Last EPS Surprise | -1.19% |
ABR | 2.95 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -6.47 |
Next Year | -5.11 |
EPS (TTM) | -6.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.06M | 12.18M | 38.65M | 103.43M |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 12.36M | 16.35M | 45.27M | 195.20M |
Low Estimate | 8.17M | 9.93M | 35.37M | 48.34M |
Year ago Sales | 2.72M | 77.97M | 86.46M | 38.65M |
Year over Year Growth Est. | 269.93% | -84.38% | -55.29% | 167.60% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.54 | -1.45 | -6.47 | -5.11 |
# of Estimates | 12 | 10 | 12 | 12 |
Most Recent Consensus | -1.59 | -1.58 | -6.67 | -5.78 |
High Estimate | -1.22 | -0.88 | -5.47 | -3.20 |
Low Estimate | -1.71 | -1.65 | -6.97 | -7.25 |
Year ago EPS | -2.81 | -0.55 | -9.05 | -6.47 |
Year over Year Growth Est. | 45.20% | -163.64% | 28.51% | 20.97% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 7 | 6 | 8 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 4 | 4 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.54 | -1.45 | -6.47 | -5.11 |
7 Days Ago | -1.54 | -1.45 | -6.47 | -5.11 |
30 Days Ago | -1.55 | -1.47 | -6.49 | -5.20 |
60 Days Ago | -1.62 | -1.53 | -6.64 | -4.80 |
90 Days Ago | -1.60 | -1.53 | -6.48 | -4.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.54 | -1.45 | -6.47 | -5.11 |
Zacks Consensus Estimate | -1.54 | -1.45 | -6.47 | -5.11 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.70 | -1.80 | -0.55 | -2.81 | NA |
Estimate | -1.68 | -1.63 | -1.18 | -2.64 | NA |
Difference | -0.02 | -0.17 | 0.63 | -0.17 | 0.07 |
Surprise | -1.19% | -10.43% | 53.39% | -6.44% | 8.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more